Latest Tenpoint Therapeutics News & Updates

See the latest news and media coverage for Tenpoint Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Tenpoint Therapeutics

Eye therapeutics developer for aging vision disorders

tenpointtherapeutics.com
Headquarters
Irvine, United States
Founded year
2019
Company type
Private company
Number of employees
125–200

Last updated

Latest news about Tenpoint Therapeutics

In short: Tenpoint Therapeutics launched YUVEZZI in the U.S. and expanded its leadership team following a merger with Visus Therapeutics and FDA approval.

Company announcements

Tenpoint Therapeutics

Tenpoint Therapeutics announces FDA approval of YUVEZZI

YUVEZZI is the first dual-agent eye drop for presbyopia treatment, based on Phase 3 trials, available Q2 2026.

Unlock all announcements with a

Media coverage

Yahoo Finance

YUVEZZI™ from Tenpoint Therapeutics, Ltd. Is Now Available Nationwide Across the United States

Tenpoint Therapeutics, Ltd., a global, commercial-stage ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced that YUVEZZI...

Unlock all articles with a

Never miss news about Tenpoint Therapeutics

Track Tenpoint Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.